Please provide your email address to receive an email when new articles are posted on . 47.5% of patients treated with glucocorticoids reported myopathy. Cumulative dosage, age, sex and weight were ...

This report describes a female patient in her 60s with an immune-mediated necrotising myopathy (IMNM) occurring after semaglutide use. She was found to have progressive dysphagia, dysphonia, proximal ...

Considering taking a vitamin or supplement to treat Vitamin D Deficiency-Related Proximal Myopathy? Below is a list of common natural remedies used to treat or reduce the symptoms of Vitamin D ...

Please provide your email address to receive an email when new articles are posted on . In patients with nonobstructive hypertrophic cardiomyopathy, treatment with mavacamten was well tolerated and ...

Novel mavacamten had a big impact on quality of life in obstructive hypertrophic cardiomyopathy, according to a secondary analysis of the EXPLORER-HCM trial. The cardiac myosin inhibitor improved ...

The Defibrillators in Non-ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) trial was conducted to evaluate the prophylactic implantation of an ICD to prevent sudden death in patients with ...

Alnylam Canada ULC is pleased to announce it has received a positive recommendation from Canada's Drug Agency (CDA) for the public reimbursement of its RNAi therapeutic, AMVUTTRA®.1 In December 2025, ...